News
Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for patient needs across a variety of therapeutic areas including: pain management, mental health, gut health, diabetes, and allergies.
Medlab specialise in solutions that can provide improved bioavailability leading to better outcomes, fewer side effects and improved quality of life through agile innovative research and expertise in both large and small molecule delivery, throughout the entire supply chain process, from concept to the manufactured end product.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
ASX health stocks today: AdAlta (ASX:1AD) leads after successful Phase I study
Health & Biotech
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia
Health & Biotech
ScoPo’s Powerplays: Quarterlies to dictate price moves, as Nanosonics and Neuren come into play
Health & Biotech
‘Tidal wave of demand’: There’s a pot shortage in New York
Health & Biotech
Weed Week: Europe or North America, where’s the place to be for ASX cannabis stocks?
Health & Biotech
Weed Week: 4/20 can’t help ASX cannabis companies
Health & Biotech
Virginia first southern US state to legalise cannabis, ASX-listed Medlab gets first nod from Europe patent office
Health & Biotech
Imugene gains 10pc on cancer vaccine progress; 3 other biotechs getting patents
News
Market highlights and 5 ASX small caps to watch on Wednesday
News
Closing Bell: Today’s biggest small cap winners on the ASX
News
Rise and Shine: What you need to know before the ASX opens
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
Health & Biotech
COVID-19 isn’t stopping ASX health stocks’ ambitions to make it in Europe and the US
Experts
ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X
Health & Biotech
3 cannabis players discuss how to view the sector through a biotech lens
Experts
ScoPo’s health powerplays: ‘Cannabis stocks went on a ride’
Health & Biotech